Blog

Viewpoint on the FDA marketing authorization for MIRA

Following the welcome announcement that Virtual Incision has received FDA marketing authorization for MIRA, we spoke to Fernando Pacheco, investment director at Endeavour Vision, and board director at Virtual Incision to understand what the breakthrough will mean for healthcare providers, surgeons and patients alike… Let’s start with [...]

2024-03-01T13:46:14+00:00March 1st, 2024|All News, Blog, Investment, Medtech|

Neurovascular technology Q&A with Endeavour Vision’s Investment Manager, Toby AuWerter

As an investor in healthcare technologies, we are always on the lookout for areas of unmet need where new technologies have the potential to improve patient outcomes. The neurovascular technology sector is one such field. Neurovascular conditions occur when an area of the brain is affected by restricted blood flow [...]

2023-03-28T14:18:15+01:00March 7th, 2023|All News, Blog, Medtech|

Miach Orthopaedics Secures $40 Million Financing – Funds to Expand U.S. Commercialization of BEAR® Implant for Treatment of ACL Tears

WESTBOROUGH, Massachusetts – January 24, 2023 – Miach Orthopaedics, Inc., a company transforming the treatment of anterior cruciate ligament (ACL) tears from reconstruction to restoration with the Bridge-Enhanced ACL Restoration (BEAR®) Implant, today announced closing of a $40 million financing round. The funds will enable ongoing operations and expand [...]

2023-03-28T14:20:57+01:00January 25th, 2023|All News, Blog, Company News, Investment, Medtech|

Relievant Medsystems Announces Highest Quality of Evidence Ranking for Basivertebral Nerve Ablation in ASPN Back Guideline for Interventional Low Back Pain Treatments

MINNEAPOLIS, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Relievant Medsystems, a company dedicated to transforming the diagnosis and treatment of vertebrogenic pain, a type of chronic low back pain (CLBP), today announced that basivertebral nerve (BVN) ablation received a Grade A Quality of Evidence Ranking with High Level of Certainty [...]

2023-03-30T14:43:26+01:00January 9th, 2023|All News, Blog|

Interview with Tyler Binney, CEO of Relievant

Tyler Binney joined Relievant as President and CEO in 2021. We interviewed him to learn about Relievant’s breakthrough Intracept® Procedure, which could bring relief to tens of millions of US adults living with disabling vertebrogenic lower back pain. Tell us about chronic lower back pain. How does it impact [...]

2023-03-30T15:21:22+01:00December 13th, 2022|All News, Blog|

HealthJoy Raises $60M Series D to Power HR Leaders Through a New Era of Workplace and Healthcare Benefits

CHICAGO, Oct. 27, 2022 - HealthJoy, a healthcare navigation platform that drives benefits satisfaction, improves care outcomes, improves employee satisfaction and reduces HR burden, today announced it has raised $60M in Series D funding. Valspring Capital led the round with participation from new investors Endeavour Vision and CIBC Innovation [...]

2023-03-28T14:41:47+01:00October 27th, 2022|All News, Blog, Company News, Investment, Medtech|

Endeavour Vision adds Kestra Medical Technologies to EMG II Portfolio

Endeavour Vision is pleased to announce the addition of Kestra Medical Technologies to its portfolio – a company poised to disrupt the billion-dollar wearable cardioverter defibrillator (WCD) market. Kestra is bringing much-needed innovation to patients at risk of sudden cardiac arrest. Kestra’s ASSURE WCD automatically detects the irregularities in [...]

2023-03-28T14:42:45+01:00August 26th, 2022|All News, Blog, Company News, Investment, Medtech|
Go to Top